ORCL ORACLE CORP
Price Chart
Executive Summary
JP Morgan upgraded Oracle from Neutral to Overweight on March 11, cutting its price target to $210 from $230 but still implying 30% upside from the current $161.39. The call was part of a cluster of 18 firms updating coverage that day, including Oppenheimer, Citigroup, and BofA. JP Morgan has a 57% accuracy rate on 7 Oracle calls (avg return 4.5%), slightly above the average of covering firms. The consensus is heavily bullish: 40 of 51 analysts rate Buy or Strong Buy (78%), with a mean target of $243.23 (+51%). JP Morgan's $210 target is below the median of $220 and the mean, making it a relatively conservative bullish call. Momentum is supportive with 1 upgrade and 0 downgrades in 30 days, and FY+1 EPS estimates have been revised up 3 times versus 1 down. However, insider selling ($4.2M combined), modest congressional sells, and an elevated short interest of 60.4% of trade volume create caution. The upgrade reinforces the bullish thesis but the PT cut and cross-platform selling suggest tempered near-term expectations.
Impact Score
Consensus & Targets
Of 51 analysts covering Oracle, 40 rate it Buy or Strong Buy (78%), 10 rate Hold (20%), and 1 rates Sell (2%). The consensus is overwhelmingly bullish, with 16 Strong Buy and 24 Buy ratings. JP Morgan's upgrade aligns with this sentiment, though its target is below the average.
Current price of $161.39 implies 50.7% upside to the mean target of $243.23 (39 analysts providing PTs) and 36.3% to the median of $220. Targets range from a low of $155 (below current price) to a high of $400 (Guggenheim). JP Morgan's new PT of $210 sits below the mean and median, making it a more conservative bullish stance.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-04-29 | Wedbush | reiterate | Outperform | $225.00 |
| 2026-04-24 | Wedbush | initiate | Outperform | $225.00 |
| 2026-04-23 | Morgan Stanley | maintain | Equal-Weight | $207.00 |
| 2026-04-07 | Stephens & Co. | reiterate | Equal-Weight | $254.00 |
| 2026-03-16 | Mizuho | maintain | Outperform | $320.00 |
| 2026-03-13 | Guggenheim | reiterate | Buy | $400.00 |
| 2026-03-12 | Citigroup | maintain | Buy | $320.00 |
| 2026-03-11 | Stifel | maintain | Buy | $220.00 |
| 2026-03-11 | Barclays | maintain | Overweight | $240.00 |
| 2026-03-11 | BMO Capital | maintain | Outperform | $200.00 |
In the past 30 days, Oracle saw 1 upgrade and 0 downgrades. EPS estimate revisions are slightly positive: FY+1 estimates have 3 upward revisions vs 1 downward, while the current quarter (0q) has 0 up and 2 down. Overall, forward estimates are edging higher, supporting the bullish narrative.
Firm Track Record — JP Morgan
JP Morgan accuracy: 55% on 5703 calls | avg return: 5.6%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Oppenheimer | 100% | 2/2 | 16.8% | top tier |
| WestPark Capital | 100% | 2/2 | 50.7% | top tier |
| Keybanc | 71% | 5/7 | 11.9% | top tier |
| Deutsche Bank | 67% | 2/3 | 13% | top tier |
| Morgan Stanley | 67% | 6/9 | 14.9% | top tier |
| UBS | 64% | 7/11 | 5.6% | top tier |
| Guggenheim | 64% | 7/11 | 12.2% | top tier |
| Jefferies | 63% | 5/8 | 9.5% | top tier |
| B of A Securities | 63% | 5/8 | 6.8% | top tier |
| Stifel | 63% | 5/8 | 7.7% | top tier |
JP Morgan has a 57% accuracy rate on 7 Oracle calls with an average return of 4.5%, above the average of all covering firms. However, top-tier firms perform better: Oppenheimer (100% on 2 calls, +16.8% avg return), WestPark Capital (100% on 2 calls, +50.7%), and Keybanc (71% on 7 calls, +11.9%). JP Morgan's record is solid but not elite.
Earnings Estimates
Next earnings: Jun 9, 2026
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| +1q | $1.68 | $1.51 — $1.84 | $19.0B | ↑0 ↓0 |
| +1y | $8.03 | $7.47 — $9.26 | $88.5B | ↑1 ↓0 |
| 0y | $7.46 | $6.59 — $7.69 | $67.2B | ↑1 ↓0 |
| 0q | $1.96 | $1.76 — $2.03 | $19.1B | ↑0 ↓0 |
Cross-Platform Signals
Insider trading shows recent sales: Levey Stuart sold $2.64M on Apr 16, and Magouyrk Clayton sold $1.55M on Feb 9. Congressional trades are mixed: Rep. Moskowitz sold $32K-$80K total in March, while Rep. McCaul bought $1K-$15K in Feb. Institutional flows are divergent: Norges Bank initiated a $4.34B position and Two Sigma doubled its stake (+1,370%), but two funds exited completely. Short interest is elevated at 60.4% of trade volume, indicating bearish positioning. The bullish analyst signal diverges from insider selling and high short interest.
Actionable Insight
The upgrade adds credibility to the bullish consensus, but the conservative PT cut and insider selling urge caution. Traders should wait for the June 9 earnings for clearer signals before adding to positions.
Documents Analyzed
Report based on filing metadata.
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 1, 2026
20d ago
|
ANALYST-UPGRADE
| $162.75 $152.82 | ▼ −6.10% | ▼ −3.91% | $191.68 (+17.78%) |
|
Apr 24, 2026
27d ago
|
ANALYST-UPGRADE
| $173.27 $161.39 | ▼ −6.85% | ▼ −7.76% | $191.68 (+10.62%) |
|
Mar 30, 2026
7w ago
|
Court Ruling
| $138.79 $142.81 | ▲ +2.90% | ▼ −1.40% | $191.68 (+38.11%) |
|
Feb 28, 2026
11w ago
|
Institutional Cluster
| $149.18 $151.54 | ▲ +1.58% | ▲ +2.79% | $191.68 (+28.49%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access